SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-125782
Filing Date
2022-04-28
Accepted
2022-04-28 09:54:33
Documents
15
Period of Report
2022-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d283951d8k.htm   iXBRL 8-K 53562
2 EX-99.1 d283951dex991.htm EX-99.1 978047
3 EX-99.2 d283951dex992.htm EX-99.2 11870
4 EX-99.3 d283951dex993.htm EX-99.3 16393
  Complete submission text file 0001193125-22-125782.txt   1336841

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220428.xsd EX-101.SCH 2534
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220428_lab.xml EX-101.LAB 18035
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220428_pre.xml EX-101.PRE 11326
9 EXTRACTED XBRL INSTANCE DOCUMENT d283951d8k_htm.xml XML 3444
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 22862713
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences